Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications
- 1 August 2002
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 23 (8), 360-366
- https://doi.org/10.1016/s0165-6147(02)02053-9
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Are endothelium-derived hyperpolarizing and contracting factors isoprostanes?Trends in Pharmacological Sciences, 2002
- Vascular Biology of the IsoprostanesJournal of Vascular Research, 2001
- Characterization of the effects of isoprostanes on platelet aggregation in human whole bloodBritish Journal of Pharmacology, 2001
- Olive Oils Rich in Natural Catecholic Phenols Decrease Isoprostane Excretion in HumansBiochemical and Biophysical Research Communications, 2000
- Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s diseaseFree Radical Biology & Medicine, 1999
- Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in VivoJournal of Biological Chemistry, 1999
- Metabolism of 8‐iso‐prostaglandin F2αFEBS Letters, 1998
- Identification and Relative Quantitation of F2-Isoprostane Regioisomers Formed in vivo in the RatFree Radical Biology & Medicine, 1997
- Evidence for the Formation of F3-Isoprostanes during Peroxidation of Eicosapentaenoic AcidBiochemical and Biophysical Research Communications, 1997
- Non‐enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1Recueil des Travaux Chimiques des Pays-Bas, 1967